Generate Biomedicines, Inc. (NASDAQ:GENB) IPO
IPO
Priced at US$16.00 a share on Feb 26, 2026.
- Price
- US$16.00 a share
- Shares offered
- 25,000,000 shares of common stock
- Offering size
- US$400 million
- Underwriters' option
- Up to 3,750,000 more shares
- Listing
- GENB on the Nasdaq Global Select Market
- Underwriters
- Goldman Sachs & Co. LLC, Morgan Stanley, Piper Sandler, Guggenheim Securities, Cantor · In the order on the cover
- Shares delivered
- On or about Mar 2, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 23, 2025 |
| Filed publicly | Feb 4, 2026 |
| Amended twice | Newest Feb 23, 2026 |
| Shares registered with an exchange | Feb 24, 2026 |
| Declared effective by the SEC | Feb 26, 2026 |
| Final prospectus, with the price | Feb 27, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 27, 2026 |
| EFFECT · Notice that a registration is effective | Feb 26, 2026 |
| CERT · Exchange's certificate of listing | Feb 26, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 24, 2026 |
| S-1/A · Registration statement, amended | Feb 23, 2026 |
| S-1/A · Registration statement, amended | Feb 13, 2026 |
| S-1 · Registration statement | Feb 4, 2026 |
| DRS · Draft registration statement | Dec 23, 2025 |
From the cover of the final prospectus (424B4) filed Feb 27, 2026